Can't agree with you. Brokers such as UBS are meant to have a good understanding of the company they are rating. They have, or should have people with intimate knowledge of the industry, the market and competitors. They rated COH with a target SP of $240. Two days later it closes at $323. How did they get it so wrong and have they revised their target price?
Ann: Cochlear Upgrades FY24 Earnings Guidance, page-7
Add COH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$337.11 |
Change
5.240(1.58%) |
Mkt cap ! $21.73B | |||
| Open | High | Low | Value | Volume |
| $335.86 | $337.66 | $334.43 | $5.287M | 15.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5 | $337.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $337.11 | 4 | 2 |
View Market Depth
| Last trade - 10.33am 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$337.47 |
Change
5.240 ( 1.74 %) |
||||
| Open | High | Low | Volume | ||
| $335.05 | $337.84 | $334.43 | 651 | ||
| Last updated 10.52am 16/05/2024 ? | |||||
| COH (ASX) Chart |